Insects May Hold Key to New Drugs
ABC News
10/15/2001
By Ben Hirschler
Bugs-To-Drugs Firm Taps China
for Insect Medicines
LONDON (Reuters) - Butterflies and beetles may hold
the key to new drugs to fight infection and other diseases,
according to a French biotechnology company that is working
with Chinese scientists in the hunt for insect-based
medicines.
Entomed SA announced plans on Monday to tap into Chinese
know-how through a collaboration with the Shanghai Institute
of Entomology.
The Strasbourg-based start-up, which hopes to float
on the stock market around the end of 2003, claims to
be the only firm in the world focused on insect medicine.
It hopes to start clinical trials on its first experimental
drug around the middle of next year.
Chief Executive Mario Thomas, in London for a European
Biopartnering conference, argued that while 50% of modern
medicines were derived from plants and microbes, insects
had been neglected.
The world's 2 million catalogued species of insects
have developed sophisticated immune systems over 500
million years, allowing them produce a range of molecules
to fight off bacteria and other pathogens, he said.
Entomed's first drug candidate, ETD 151, was extracted
from a South American butterfly larva and is scheduled
to commence clinical trials in the latter half of 2002
for treating life-threatening fungal infections acquired
in hospitals.
Further products are in development to fight a range
of other diseases and to promote wound healing.
The firm hopes to uncover further leads through its
work with the Shanghai Institute, which will supply insect
extracts and give Entomed an insight into use of insects
in traditional Chinese medicine.
Extracts of crushed insects have been used for hundreds
of years in China to treat a range of ailments, including
infections, inflammation and stomach complaints.
Thomas said his 30-strong steam of scientists had so
far only scratched the surface of insects' chemical arsenals,
sampling a mere 200 species since the Entomed's inception
in 1999.
Nonetheless, a few clues have emerged as to which bugs
contain the most promising agents.
"One thing we've found is that insects that go
through full metamorphosis tend to produce more potent
peptides (small proteins that can be used as drugs)," Thomas
told Reuters.